Search research articles

Search research articles

Related Experiment Videos

Mesenteric venous thrombosis: a case report

D E Geyer¹, L E Krenning

¹Department of Family Practice, College of Medicine, University of Oklahoma, Tulsa.

The Journal of Family Practice

|April 1, 1993

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

You're the flight surgeon: severe headache.

Aviation, space, and environmental medicine·1996

Same author

The role of the teaching nursing home in residency education.

The Journal of the Oklahoma State Medical Association·1985

Same author

Pocket computer program for performing nutritional assessment on hospitalized patients.

Computers in biology and medicine·1983

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mesenteric venous thrombosis is rare, diagnosed clinically by severe pain. Treatment involves surgery and anticoagulation, with investigation for inherited clotting disorders.

Area of Science:

Gastroenterology
Vascular Surgery
Hematology

Background:

Mesenteric venous thrombosis (MVT) is an infrequent vascular condition.
Diagnosis is primarily clinical, relying on patient-reported symptoms.

Observation:

The hallmark clinical presentation of MVT is abdominal pain disproportionate to physical examination findings.
Surgical intervention, including thrombectomy and resection of compromised bowel/mesentery, is a primary treatment modality.

Findings:

In cases without trauma or infection, inherited anticoagulant deficiencies should be investigated.
These deficiencies follow an autosomal dominant inheritance pattern.

Implications:

Warfarin sodium therapy is the recommended treatment for identified anticoagulant deficiencies.

Related Experiment Videos

Understanding the genetic basis of MVT can guide long-term patient management and family screening.